Soft Gelatin Capsule Market Overview
The Soft Gelatin Capsule Market was valued at USD 4.6 Billion in 2024 and is expected to grow from USD 4.8 Billion in 2025 to USD 7 Billion by 2035, registering a CAGR of 3.9% during the forecast period from 2026 to 2035. Soft gelatin capsules are widely used for pharmaceutical, nutraceutical, and dietary supplement applications because they can encapsulate liquids, oils, and other formulations that may be difficult to manufacture in conventional solid dosage forms.
Growing demand for convenient oral dosage formats is supporting the expansion of the market. Softgels offer advantages such as ease of swallowing, dosage consistency, protection of active ingredients, and suitability for oil-based formulations. The growing consumption of nutritional supplements and increasing demand for pharmaceutical products are also contributing to market development.
North America is expected to maintain a leading position because of its established pharmaceutical and nutraceutical industries, high healthcare expenditure, and strong consumer demand for dietary supplements. Europe also represents an important market, supported by pharmaceutical manufacturing capabilities and increasing interest in functional nutrition. Asia Pacific is expected to witness continued expansion as pharmaceutical production increases, consumer health awareness improves, and supplement consumption rises.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/sample-request?id=647335
Key Companies in the Soft Gelatin Capsule Market
Catalent
Capsugel
Aenova Group
Sirio Pharma
Procaps Group
Lonza
EuroCaps
Medi-Caps
Captek Softgel International
Robinson Pharma
Soft Gel Technologies
Strides Pharma Science
Nutralab Canada
Geltec
Captek
Pharmaceutical applications remain a major contributor to soft gelatin capsule demand. Softgels can provide an effective delivery format for active pharmaceutical ingredients and are used across several therapeutic categories. Nutraceutical applications are also expanding as consumers increasingly use vitamins, minerals, herbal products, omega-3 supplements, and other nutritional products.
Manufacturing technology is evolving to improve production efficiency, capsule uniformity, and formulation compatibility. Manufacturers are investing in encapsulation equipment, automated production systems, and quality-control technologies. Advances in gelatin alternatives are also creating opportunities for vegetarian and plant-based capsule formats, particularly in markets where consumers are increasingly interested in non-animal-derived products.
Consumer preferences are influencing product development as well. Smaller capsule sizes, improved taste and odor characteristics, and enhanced stability are being considered in the development of new softgel products. Online distribution is also expanding the availability of supplements and pharmaceutical products, giving manufacturers additional opportunities to reach consumers directly.
Recent Developments and Market Trends:
Catalent expanded its softgel manufacturing capabilities to support pharmaceutical and nutraceutical customers across multiple markets.
Aenova Group continued investing in advanced softgel manufacturing and production capacity to meet increasing demand.
Sirio Pharma expanded its portfolio of softgel and nutraceutical delivery solutions for international customers.
Plant-based and vegetarian softgel alternatives are receiving increasing attention as consumer preferences change.
Automation is being integrated into manufacturing processes to improve production efficiency and consistency.
Online retail is expanding access to nutritional supplements and softgel products.
Market Segmentation:
By application, the market includes pharmaceuticals, nutraceuticals, cosmetics, and other applications. Pharmaceutical applications represent a major segment because softgels provide an established dosage format for several drug formulations. Nutraceuticals are also an important growth area because of increasing consumption of dietary supplements and wellness products.
By type, the market includes gelatin-based and non-gelatin-based capsules. Gelatin remains widely used because of its established manufacturing characteristics, while non-gelatin formulations are gaining attention from consumers seeking plant-based alternatives.
By formulation, the market covers liquid-filled, semi-solid, and other formulations. Liquid-filled capsules are particularly relevant because softgel technology provides an effective method for encapsulating oils and other liquid ingredients.
By end user, pharmaceutical manufacturers, nutraceutical companies, contract manufacturers, and other organizations contribute to market demand. Contract manufacturing is increasingly relevant as pharmaceutical and supplement companies seek specialized production capabilities without building extensive internal manufacturing infrastructure.
Reasons to Buy the Report:
Understand the global market size and forecast through 2035.
Analyze application, capsule type, formulation, end user, and regional market segments.
Assess demand from pharmaceutical and nutraceutical applications.
Review advances in softgel manufacturing and encapsulation technologies.
Understand the growing interest in plant-based and non-gelatin alternatives.
Examine the influence of online distribution and changing consumer preferences.
Review major companies and their market-development activities.
Identify emerging opportunities across pharmaceutical, dietary supplement, and functional nutrition applications.
Future Outlook:
The Soft Gelatin Capsule Market is expected to grow steadily as pharmaceutical and nutraceutical manufacturers continue to use convenient oral dosage formats. Demand for liquid-filled formulations, dietary supplements, and functional nutritional products should remain important market drivers. Manufacturing automation and advances in capsule materials are likely to improve production efficiency and expand formulation possibilities. The growing interest in vegetarian and plant-based alternatives may also encourage manufacturers to develop additional non-gelatin solutions. Continued pharmaceutical production and increasing supplement consumption are expected to support market development through 2035.
➤➤Explore Our Latest Related Reports:
